Literature DB >> 11713801

Application of antisense oligonucleotides for gene functionalization and target validation.

C F Bennett1, L M Cowsert.   

Abstract

The Human Genome Project (complete sequencing of the human genome) will be complete soon and the information made available to the biomedical community. Although the project is not yet complete, it has dramatically changed the practice of biomedical sciences. With enormous amounts of information available from sequencing efforts, increasing demands are being put on researchers to quickly determine the biochemical function of novel molecular targets and to validate them as appropriate for drug discovery endeavors. Antisense oligonucleotides are an ideal technology for gene functionalization and target validation. They are an efficient methodology for gene functionalization and target validation and are a proven technology. Antisense technology can answer questions with a high degree of precision and it is a versatile technology. In this review the use of antisense oligonucleotides as a research tool for gene functionalization and target validation is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11713801

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  5 in total

1.  mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides.

Authors:  Hong-Yan Zhang; Jianping Mao; Daixing Zhou; Yunhe Xu; Håkan Thonberg; Zicai Liang; Claes Wahlestedt
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

2.  mRNA fusion constructs serve in a general cell-based assay to profile oligonucleotide activity.

Authors:  Dieter Hüsken; Fred Asselbergs; Bernd Kinzel; Francois Natt; Jan Weiler; Pierre Martin; Robert Häner; Jonathan Hall
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

3.  Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses.

Authors:  V Bitko; S Barik
Journal:  BMC Microbiol       Date:  2001-12-20       Impact factor: 3.605

4.  The use of nano-sized acicular material, sliding friction, and antisense DNA oligonucleotides to silence bacterial genes.

Authors:  Yuya Mitsudome; Mamiko Takahama; Jun Hirose; Naoto Yoshida
Journal:  AMB Express       Date:  2014-09-04       Impact factor: 3.298

5.  Profiled support vector machines for antisense oligonucleotide efficacy prediction.

Authors:  Gustavo Camps-Valls; Alistair M Chalk; Antonio J Serrano-López; José D Martín-Guerrero; Erik L L Sonnhammer
Journal:  BMC Bioinformatics       Date:  2004-09-22       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.